Virpax Pharmaceuticals's total assets for Q3 2023 were $13.04M, a decrease of -18.26% from the previous quarter. VRPX total liabilities were $6.53M for the fiscal quarter, a 79.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.